What does epidemiology tell us about risk factors for herpes zoster?
- PMID: 14720565
- DOI: 10.1016/s1473-3099(03)00857-0
What does epidemiology tell us about risk factors for herpes zoster?
Abstract
Reactivation of latent varicella zoster virus as herpes zoster is thought to result from waning of specific cell-mediated immunity, but little is known about its determinants in individuals with no underlying immunosuppression. We systematically reviewed studies of zoster epidemiology in adults and analysed data from a large morbidity study to identify factors that might be modulated to reduce the risk of zoster. Annual zoster incidence in population-based studies varied from 3.6-14.2/10(3) in the oldest individuals. Risk factors identified in analytical studies that could explain this variation included age, sex, ethnicity, genetic susceptibility, exogenous boosting of immunity from varicella contacts, underlying cell-mediated immune disorders, mechanical trauma, psychological stress, and immunotoxin exposure. Our review highlights the lack of information about risk factors for zoster. We suggest areas of research that could lead to interventions to limit the incidence of zoster. Such research might also help to identify risk factors for age-related immune decline.
Similar articles
-
Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study.Lancet. 2002 Aug 31;360(9334):678-82. doi: 10.1016/S0140-6736(02)09837-9. Lancet. 2002. PMID: 12241874
-
The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.Vaccine. 2006 May 1;24(18):3946-52. doi: 10.1016/j.vaccine.2006.02.017. Epub 2006 Feb 24. Vaccine. 2006. PMID: 16564115
-
The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix.Clin Ther. 2015 Apr 1;37(4):816-829.e10. doi: 10.1016/j.clinthera.2014.12.017. Epub 2015 Feb 26. Clin Ther. 2015. PMID: 25726457
-
The effect of vaccination on the epidemiology of varicella zoster virus.J Infect. 2002 May;44(4):211-9. doi: 10.1053/jinf.2002.0988. J Infect. 2002. PMID: 12099726 Review.
-
Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence.J Am Osteopath Assoc. 2009 Jun;109(6 Suppl 2):S13-7. J Am Osteopath Assoc. 2009. PMID: 19553630 Review.
Cited by
-
How sex and age affect immune responses, susceptibility to infections, and response to vaccination.Aging Cell. 2015 Jun;14(3):309-21. doi: 10.1111/acel.12326. Epub 2015 Feb 26. Aging Cell. 2015. PMID: 25720438 Free PMC article. Review.
-
Identifying optimal vaccination scenarios to reduce varicella zoster virus transmission and reactivation.BMC Med. 2022 Oct 8;20(1):387. doi: 10.1186/s12916-022-02534-7. BMC Med. 2022. PMID: 36209074 Free PMC article.
-
Burden of Herpes Zoster in Individuals with Immunocompromised Conditions and Autoimmune Diseases in the Republic of Korea: A Nationwide Population-Based Database Study.Infect Dis Ther. 2023 Dec;12(12):2771-2790. doi: 10.1007/s40121-023-00894-y. Epub 2023 Dec 12. Infect Dis Ther. 2023. PMID: 38085494 Free PMC article.
-
Risk Factors for Herpes Zoster Among Adults.Open Forum Infect Dis. 2016 Jun 11;3(3):ofw119. doi: 10.1093/ofid/ofw119. eCollection 2016 Sep. Open Forum Infect Dis. 2016. PMID: 27382600 Free PMC article.
-
In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs.J Virol. 2012 Mar;86(5):2641-52. doi: 10.1128/JVI.06620-11. Epub 2011 Dec 21. J Virol. 2012. PMID: 22190713 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical